Announce Date | 07/08/2025 |
EPS Normalized Actual | $0.47 (Beat by $0.17) |
EPS GAAP Actual | $0.47 (Beat by $0.17) |
Revenue Actual | $0.324251B |
Revenue Surprise | Beat by $324.251M |
Announce Date | 08/28/2025 (Pre-Market) |
EPS Normalized Estimate | $0.31781 |
EPS GAAP Estimate | $0.31781 |
Revenue Estimate | $0.340258969B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2028 | 0 | INF | 0 | 0 | 0 |
Aug 2027 | 2.48333 | 9.43 | 2.45453 | 2.52113 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | -0.01 | -0.34235 | 0.324251B | 100% | -6.54M |
FQ2 2016 (May 2016) | -0.0325 | -0.0325 | 0.149609B | 100% | 149.61M |
FQ3 2016 (Aug 2016) | 0 | 0 | 0.146201B | 100% | 146.2M |
FQ4 2016 (Nov 2016) | -0.0774 | -0.0774 | 0.159344B | 100% | 159.34M |
FQ1 2017 (Feb 2017) | -0.0564 | -0.0564 | 0.171954B | 100% | 171.95M |
FQ2 2017 (May 2017) | 0.28 | 0.28 | 0.206974B | 27.72% | 206.97M |
FQ3 2017 (Aug 2017) | -0.24 | -0.24 | 0.223019B | 34.44% | 223.02M |
FQ4 2017 (Nov 2017) | 0.49 | 0.49 | 0.265409B | 39.96% | 265.41M |
FQ4 Announce Date
08/28/2025 (Pre-Market)
Consensus EPS Estimates
0.31781
Consensus Revenue Estimates
0.340258969B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Aug 2027) | 0.79 | -- | 0.7662 | 0.84048 | 3 |
FQ2 2027 (May 2027) | 0.71 | -- | 0.68861 | 0.75537 | 3 |
FQ1 2027 (Feb 2027) | 0.61 | -- | 0.59162 | 0.64898 | 3 |
FQ4 2026 (Nov 2026) | 0.53 | -- | 0.51403 | 0.56387 | 3 |
FQ3 2026 (Aug 2026) | 0.52667 | -- | 0.5108 | 0.56032 | 3 |
FQ2 2026 (May 2026) | 0.505 | 101.98 | 0.48979 | 0.53727 | 3 |
FQ1 2026 (Feb 2026) | 0.44286 | -- | 0.42952 | 0.47116 | 3 |
FQ4 2025 (Nov 2025) | 0.43571 | -- | 0.42258 | 0.46355 | 4 |
FQ3 2025 (Aug 2025) | 0.31781 | -- | 0.30824 | 0.33812 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Aug 2027) | 0.44B | -- | 0.43B | 0.46B | 4 |
FQ2 2027 (May 2027) | 0.43B | -- | 0.42B | 0.45B | 5 |
FQ1 2027 (Feb 2027) | 0.42B | -- | 0.41B | 0.44B | 6 |
FQ4 2026 (Nov 2026) | 0.42B | -- | 0.41B | 0.44B | 6 |
FQ3 2026 (Aug 2026) | 0.39B | -- | 0.39B | 0.41B | 3 |
FQ2 2026 (May 2026) | 0.38B | 15.43 | 0.37B | 0.4B | 3 |
FQ1 2026 (Feb 2026) | 0.36B | -- | 0.36B | 0.38B | 3 |
FQ4 2025 (Nov 2025) | 0.36B | -- | 0.36B | 0.38B | 2 |
FQ3 2025 (Aug 2025) | 0.34B | -- | 0.33B | 0.36B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 0.33235 | -0.01 | -0.34235 | 3423.5% |
FQ2 2016 (May 2016) | -0.0325 | -0.0325 | 100% | |
FQ3 2016 (Aug 2016) | 0 | 0 | NAN% | |
FQ4 2016 (Nov 2016) | -0.0774 | -0.0774 | 100% | |
FQ1 2017 (Feb 2017) | -0.0564 | -0.0564 | 100% | |
FQ2 2017 (May 2017) | 0.28 | 0.28 | 100% | |
FQ3 2017 (Aug 2017) | -0.24 | -0.24 | 100% | |
FQ4 2017 (Nov 2017) | 0.49 | 0.49 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0.33B | $0.32B | $-6.54M | -2.02% |
FQ2 2016 (May 2016) | $0B | $0.15B | $149.61M | 100% |
FQ3 2016 (Aug 2016) | $0B | $0.15B | $146.2M | 100% |
FQ4 2016 (Nov 2016) | $0B | $0.16B | $159.34M | 100% |
FQ1 2017 (Feb 2017) | $0B | $0.17B | $171.95M | 100% |
FQ2 2017 (May 2017) | $0B | $0.21B | $206.97M | 100% |
FQ3 2017 (Aug 2017) | $0B | $0.22B | $223.02M | 100% |
FQ4 2017 (Nov 2017) | $0B | $0.27B | $265.41M | 100% |